missing translation for 'onlineSavingsMsg'
Läs mer

RGX-104, MedChemExpress

Produktkod. 16495346
Encompass_Preferred
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
Förpackningsstorlek:
50mg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet Förpackningsstorlek
16495346 100 mg -
16487197 5 mg -
16470787 50 mg 50mg
16460136 2 mg -
16444478 10 mg -
16443106 25 mg -
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 16495346 Leverantör Medchem Express Leverantörsnummer HY111498A
 Begränsad artikel
Beräknad leverans: 21-09-2026
Add to basket
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

MedChemExpress RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.

RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.

Specifications

Kemiskt namn eller material RGX-104
CAS 610318-54-2
Färg White
Anteckningar om renhetsgrad Research
Molekylformel C34H33ClF3NO3
Kvantitet 100 mg
Löslighetsinformation DMSO : 100 mg/mL (167.76 mM; Need ultrasonic)
LEDER O=C(O)CC1=CC=CC(OCC[C@H](N(CC2=CC=CC(C(F)(F)F)=C2Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4)C)=C1
Molekylvikt (g/mol) 596.08
Formel vikt 596.08
Procent renhet 99.35%
Kvalitet Research
Fysisk form Solid
För användning med (applikation) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.